1. Papaian A.V., Savenkova N.D. eds. [Klinicheskaya nefrologiya
detskogo vozrasta: Rukovodstvo dlya vrachey]. St. Petersburg:
Levsha; 2008. (in Russian)
2. Vozianov A.F., Maydannik V.G., Bidnyj V.G., Bagdasarova I.V. [Osnovy
nefrologii detskogo vozrasta]. Kiev: Kniga plyus; 2002. (in
Russian)
3. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitaryadrenal
axis by cytokines: actions and mechanisms of action. Physiol.
Rev. 1999; 79: 1—71.
4. Grinevich V.V., Volkova O.V., Akmaev I.G. Neyroimmunoendokrine
interactions in the system: the hypothalamus—pituitary—adrenal
cortex during inflammation. Uspekhi sovremennogo estestvoznaniya.
2003; (5): 10—4. (in Russian)
5. Besedovsky H., del Rey A., Sorkin E. et al. Immunoregulatory
feedback between interleukin-1 and glucocorticoid hormones.
Science. 1986; 233: 652—4.
6. Blalock J.E., Bost K.L. Neuroimmunoendocrinology. Progr. Allergy.
1988; 43: 1—165.
7. Biochemistry: Textbook for Universities. [Biokhimiya] / Ed. E.S.
Severin. Moscow: Geotar-Med; 2004. (in Russian)
8. Ya-Yun Huang, Mei-Ju Chen, Nan-Tsing Chiu, Hsin-Hsu Chou, KuangYen
Lin, Yuan-Yow Chiou, Adjunctive oral methylprednisolone in
pediatric acute pyelonephritis alleviates renal scarring. Pediatrics.
2011; 128(3): e496—504.
9. Pohl H.G., Rushton H.G., Park J.S., Chandra R., Majd M. Adjunctive
oral corticosteroids reduce renal scarring: the piglet model of reflux
and acute experimental pyelonephritis. J. Urol. 1999; 162(3, Pt 1):
815—20.
10. Haraoka M., Matsumoto T., Takahashi K., Kubo S., Tanaka M., Kumazawa
J. Suppression of renal scarring by prednisolone combined
with ciprofloxacin in ascending pyelonephritis in rats. J. Urol. 1994;
151(4): 1078—80.
11. Sqalli T.H., Hamzaoui H., Guiard E., Noel L.H., Fakhouri F. Severe
renal failure in acute bacterial pyelonephritis: do not forget corticosteroids.
Saudi J Kidney Dis Transpl. 2010; 21(1): 118—22.
12. Elif Bahat Özdoğan, Tuğba Özdemir, Seçil Arslansoyu Çamlar, Mustafa
İmamoğlu, Ümit Çobanoğlu, Bircan Sönmez et al. Could pyelonephritic
scarring be prevented by anti-inflammatory treatment?
An experimental model of acute pyelonephritis. BioMed. Research
International. 2014: Article ID 134940. Available at: http://dx.doi.
org/10.1155/2014/134940
13. Arushanyan E.B., Beyer E.V. Temporal organization of the immune
system activity and involvement of the epiphysis. Uspekhi fiziologicheskikh
nauk. 2006; (37): 3—10. (in Russian)
14. Arushanyan E.B. Anti-inflammatory potency of melatonin and glucocorticoid
hormones. Meditsinskiy vestnik severnogo Kavkaza.
2013; 8(4): 99—104. (in Russian)
15. Parakhonskiy A.P. Effect of melatonin on the immune system. Sovremennye
naukoemkie tekhnologii. 2007; (11): @59—9. (in Russian)
16. Slobodyan E.I. The content of serum interleukin levels in children
with chronic pyelonephritis: association with disease duration, frequency
and activity of exacerbations. Tavricheskiy mediko-biologicheskiy
vestnik. 2013; 16[3, Part 3(63)]: 130—5. (in Russian)
17. Kaladze M.M., Slobodyan E.I. Diagnostic value of markers of inflammation
and cell proliferation depending on the clinical form and
nature of chronic pyelonephritis in children. Pedіatrіya, akusherstvo
ta gіnekologіya. 2014; [1(461)]: 25—8. (in Ukrainian)
18. O’Connor W., Zenewicz L.A., Flavell R.A. The dual nature of Th17
cells: shifting the focus to fanction. Nature Immunol. 2010; 11(6):
471—6.
19. Kologrivova I.V., Kologrivova E.N., Suslova T.E. Molecular aspects
of the T helper 17 functioning. Byulleten’ sibirskoy meditsiny. 2011;
(4): 93—9. (in Russian)
20. Huang W.Y., Li Z.G., Rus H. et al. RCiC-32 mediates transforming
growth factor-beta-induced epithelial-mesenchymal transition in
human renal proximal tubular cells. J. Biol. Chem. 2009; 284(14):
9426—32.
21. Honda E. Transforming grovth factor-beta upregulates the expression
of integrin and related proteins in MRC-5 human myofibroblasts. Tohoku.
J. Exp. Med. 2010; 220(4): 319—27.
22. Poon A.M., Liu Z.M., Pang C.S. et al. Evidence for a direct action of
melatonin on the immune system. Biol. Signals. 1994; 3: 107—17.
23. Garcia-Maurino S., Gonzales-Haba M., Calvo J.R. et al. Melatonin
enhances IL-2, IL-6, and IFN-g production by human circulating
CD4+ cells. A possible nuclear receptor-mediated mechanism involving
T helper type 1 lymphocytes and monocytes. J. Immunol.
1997; 159: 574—81.
24. Konakchieva R., Kyurkchiev S., Kehayov I. et al. Selective effect of
methoxyndoles on the lymphocyte proliferation and melatonin binding
to activated human lymphoid cells. J. Neuroimmunol. 1995; 63:
125—32.
25. Mal’tsev S.V., Ishkina L.A. Physiology and Pathophysiology of melatonin.
Kazanskiy meditsinskiy zhurnal. 1999; 35: 390—3. (in Russian)
26. Grinevich V., Ma X.M., Herman J.P. et al. Effect of repeated lipopolysaccharide
administration on tissue cytokine expression and
hypothalamicpituitary-adrenal axis activity in rats. J. Neuroendocrinol.
2001; 13: 711—23.
27. Mulik A.B., Postnova M.V., Mulik Yu.A. The Total Level of Nonspecific
Reactivity of the Human Organism. [Uroven’ obshchey nespetsificheskoy
reaktivnosti organizma cheloveka]. Volgograd: Volgogradskoe
nauchnoe izdatel’stvo; 2009. (in Russian)